This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2003 Apr;8(4):369-70.

doi: 10.1038/sj.mp.4001289.

Dopamine and Parkinson's disease: is the killer in the house?

PMID: 12740592
DOI: 10.1038/sj.mp.4001289

Dopamine and Parkinson's disease: is the killer in the house?

M-F Chesselet. Mol Psychiatry. 2003 Apr.

. 2003 Apr;8(4):369-70.

doi: 10.1038/sj.mp.4001289.

Author

PMID: 12740592
DOI: 10.1038/sj.mp.4001289

No abstract available

PubMed Disclaimer

Similar articles

Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Maguire-Zeiss KA, Short DW, Federoff HJ. Maguire-Zeiss KA, et al. Brain Res Mol Brain Res. 2005 Mar 24;134(1):18-23. doi: 10.1016/j.molbrainres.2004.09.014. Brain Res Mol Brain Res. 2005. PMID: 15790526 Review.
Parkinson's disease. Dopamine may sustain toxic protein.
Couzin J. Couzin J. Science. 2001 Nov 9;294(5545):1257-8. doi: 10.1126/science.294.5545.1257a. Science. 2001. PMID: 11701896 No abstract available.
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H. Yamada M, et al. J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
Ahlskog JE. Ahlskog JE. Mov Disord. 2005 Mar;20(3):271-82. doi: 10.1002/mds.20362. Mov Disord. 2005. PMID: 15580550 Review.
Oxidative stress to dopaminergic neurons as models of Parkinson's disease.
Gille G, Hung ST, Reichmann H, Rausch WD. Gille G, et al. Ann N Y Acad Sci. 2004 Jun;1018:533-40. doi: 10.1196/annals.1296.066. Ann N Y Acad Sci. 2004. PMID: 15240412

See all similar articles

Cited by

Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms.
Wildburger NC, Hartke AS, Schidlitzki A, Richter F. Wildburger NC, et al. Front Cell Dev Biol. 2020 Nov 17;8:598446. doi: 10.3389/fcell.2020.598446. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33282874 Free PMC article. Review.
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.
Richter F, Stanojlovic M, Käufer C, Gericke B, Feja M. Richter F, et al. Neurotherapeutics. 2023 Jan;20(1):97-116. doi: 10.1007/s13311-022-01338-0. Epub 2023 Jan 30. Neurotherapeutics. 2023. PMID: 36715870 Free PMC article. Review.
Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice.
Richter F, Gabby L, McDowell KA, Mulligan CK, De La Rosa K, Sioshansi PC, Mortazavi F, Cely I, Ackerson LC, Tsan L, Murphy NP, Maidment NT, Chesselet MF. Richter F, et al. Neurobiol Aging. 2017 Mar;51:54-66. doi: 10.1016/j.neurobiolaging.2016.11.015. Epub 2016 Dec 1. Neurobiol Aging. 2017. PMID: 28038352 Free PMC article.
A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.
Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR. Chesselet MF, et al. Neurotherapeutics. 2012 Apr;9(2):297-314. doi: 10.1007/s13311-012-0104-2. Neurotherapeutics. 2012. PMID: 22350713 Free PMC article. Review.
Development of an in vitro model to evaluate the regenerative capacity of adult brain-derived tyrosine hydroxylase-expressing dopaminergic neurons.
Majd S, Smardencas A, Parish CL, Drago J. Majd S, et al. Neurochem Res. 2011 Jun;36(6):967-77. doi: 10.1007/s11064-011-0435-0. Epub 2011 Mar 6. Neurochem Res. 2011. PMID: 21380845

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information